hepatitis-b

Documents about hepatitis-b

• Dataset for integrated community-based screening of communicable and non-communicable diseases in semi-urban Nigeria (2023-2025)#20819DataCite
• Dataset for integrated community-based screening of communicable and non-communicable diseases in semi-urban Nigeria (2023-2025)#30270DataCite
• Dataset for integrated community-based screening of communicable and non-communicable diseases in semi-urban Nigeria (2023-2025)#30292DataCite
• Treatment outcome of tenofovir disoproxil fumarate (TDF) among chronic hepatitis B patients: A retrospective review in Hospital Sultanah Nur Zahirah (HSNZ)#190819USM Repository
• Efficacy of Newborn Vitamin A Supplementation in Improving Immune Function#868822ClinicalTrials.gov
• Novel Long‐Read Sequencing Method for Characterisation of Hepatitis B Transcripts Show High Expression of Chimeric HBV /Human RNA#1053115Europe PMC
• A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of TVAX-008 Injection in Chronic Hepatitis B Patients#841612ClinicalTrials.gov
• Phase III, Study to Evaluate the Efficacy of Two Different HBV Vaccination Schemes in Patients With Hepatic Cirrhosis#849892ClinicalTrials.gov
• Single-Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Pevifoscorvir Sodium (ALG-000184) in Subjects With Moderate Hepatic Impairment and in Healthy Subjects With Normal Hepatic Function#913130ClinicalTrials.gov
• Relevance of Systematic Pre-Biologic Infectious Screening in Chronic Inflammatory Rheumatic Diseases: A Retrospective Single-Center Study#288221HAL (France)
• Clinical Study of TQA3605 Tablets Combined With Nucleoside (Acid) Analogs (NAs) Drugs Compared With NAs Drugs in the Treatment of Chronic Hepatitis B Virus (HBV) Infection#852298ClinicalTrials.gov
• Safety Study of a Tenofovir-containing Drug Regimen for the Prevention of Mother-to-child Transmission of HIV and HBV#890753ClinicalTrials.gov
• Early TIPS With Polytetrafluoroethylene (PTFE) Covered Stents for Acute Variceal Bleeding in Patients With Advanced Cirrhosis#904751ClinicalTrials.gov
• A Study to Assess the Immunogenicity and Safety of GSK Biologicals' Infanrix-IPV/Hib Vaccine Administered as a Three-dose Vaccination Course at 3, 4.5 and 6 Months of Age and a Booster Dose at 18 Months of Age in Healthy Infants in Russia#136424ClinicalTrials.gov
• Score System for Prediction Risk and Early Diagnosis of HCC in HIV/HCV Patients#849067ClinicalTrials.gov
• ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk#873231ClinicalTrials.gov
• The Transparent Safety Study of the 5 in 1 (DTwP-rHepB-Hib) Combination Vaccine Produced by the Indian Serine Institute in Children of Viet Nam Healthy From 6 to 12 Weeks of Age in a 3-dose Regimen, the Interval Between Doses is 4 Weeks#981687ClinicalTrials.gov
• <i>Schistosoma mansoni</i> infections are associated with hepatosplenic organometry within the context of repeated praziquantel treatment and co-endemic infections of malaria, hepatitis B, and HIV: a population-based study in rural Uganda#398609Europe PMC
• Tenofovir Monotherapy in Patients With Chronic Hepatitis B Patients Who Had Achieved Complete Viral Suppression on Entecavir Plus Tenofovir#840845ClinicalTrials.gov
• Efficacy of Tenofovir and Emtricitabine in ARV-naive Patients With HIV/HBV Co-infection#860331ClinicalTrials.gov
• A Study to Predict Recompensation in Patients With Decompensated Cirrhosis Using Spleen Stiffness and Simple Blood Tests#859383ClinicalTrials.gov
• This is a Phase 1 Study in Which Healthy Volunteers and Participants with Chronic HBV Infection Will Receive HT-101 or Placebo and Will Be Assessed for Safety, Tolerability, Pharmacokinetics (PK), and Antiviral Activity#869285ClinicalTrials.gov
• A Study to Test the Efficacy of the HBV Vaccine and to Look at the Prevalence of HBV Infection#1007458ClinicalTrials.gov
• Orientations de gouvernance pour la validation de l’élimination de la transmission mère-enfant du VIH, de la syphilis et du virus de l’hépatite B : vue d’ensemble des structures et des responsabilités de validation aux niveaux national, régional et mondial#296424WHO IRIS
• Corrigendum: Prevalence and predictors of hepatitis B screening among pregnant women attending antenatal clinics in three primary health centres in Abeokuta, Nigeria: A cross-sectional study: Corrigendum: Prévalence et facteurs prédictifs du dépistage de l'hépatite B chez les femmes enceintes fréquentant les consultations prénatales de trois centres de santé primaires à Abeokuta, au Nigéria: une étude transversale#329012African Journals Online
• A Phase III Study to Assess the Immunogenicity and Safety of Eutravac (DTap-HB Combined Vaccine) With DTaP and Hepatitis B Vaccines in Healthy Infants#918688ClinicalTrials.gov
• Considérations essentielles pour accélérer l’élimination de la transmission mère-enfant du VIH dans des contextes de faible prévalence : leçons tirées de pays ayant obtenu leur validation#328617WHO IRIS
• The exposome perspective : environmental and infectious agents as drivers of cancer disparities in low- and middle-income countries#687086University of Pretoria Repository
• Acceptabilité, déterminants et effets d'une consultation prénatale masculine incluant dépistage, rattrapage vaccinal et accès aux droits sociaux, proposée aux pères d'enfants à naître à l'hôpital de Montreuil, Seine-Saint Denis#142630HAL (France)
• Safety,Effectiveness and Acceptability of Sino-implant II in DR#804296ClinicalTrials.gov
• Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIV#853451ClinicalTrials.gov